These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 13887961)

  • 21. Mechanism of action of staphylocoagulase and clumping factor.
    Zajdel M; Wegrzynowicz Z; Jeljaszewicz J; Pulverer G
    Contrib Microbiol Immunol; 1973; 1():364-75. PubMed ID: 4805312
    [No Abstract]   [Full Text] [Related]  

  • 22. [The state of prothrombin, plasminogen and fibrinogen in the newborn infant].
    Potron G; Droulle C; Behar C; Leroux B; Ledoyen MP; Mascre W
    Pathol Biol (Paris); 1975 Dec; 23 suppl():56-62. PubMed ID: 4759
    [TBL] [Abstract][Full Text] [Related]  

  • 23. INTRAVASCULAR COAGULATION AND FIBRINOLYSIS BY STAPHYLOCOAGULASE. COMPARISON WITH THROMBIN.
    JELJASZEWICZ J; NIEWIAROWSKI S; POPLAWSKI A; PROKOPOWICZ J; WOROWSKI K
    Thromb Diath Haemorrh; 1965 Jun; 13():457-69. PubMed ID: 14347867
    [No Abstract]   [Full Text] [Related]  

  • 24. Current views on the mechanisms of coagulase action in blood clotting.
    Tager M
    Ann N Y Acad Sci; 1974 Jul; 236(0):277-91. PubMed ID: 4608005
    [No Abstract]   [Full Text] [Related]  

  • 25. Studies on a proteolytic enzyme in human plasma; the relationship between the proteolytic activity of plasma and blood coagulation.
    RATNOFF OD; HARTMANN RC; CONLEY CL
    J Exp Med; 1950 Feb; 91(2):123-33. PubMed ID: 15404220
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Formation and properties of fibrin clots resulting from staphylocoagulase (SC) action.
    Kopeć M; Wegrzynowicz Z; Budzyński AZ; Jeljaszewicz J; Latallo ZS; Lipiński B; Kowalski E
    Thromb Diath Haemorrh; 1967 Dec; 18(3-4):475-86. PubMed ID: 5590240
    [No Abstract]   [Full Text] [Related]  

  • 27. Staphylocoagulase inhibition by pooled human gamma-globulin.
    STREITFELD MM; SALLMAN B; SHOELSON SM
    Nature; 1959 Nov; 184(Suppl 21)():1665-6. PubMed ID: 13835190
    [No Abstract]   [Full Text] [Related]  

  • 28. The role of staphylocoagulase in blood coagulation; coagulation in the absence of calcium and in the presence of fluorides, heparin, and azo dyes.
    MIALE JB
    Blood; 1949 Dec; 4(12):1317-22. PubMed ID: 15395438
    [No Abstract]   [Full Text] [Related]  

  • 29. [Reliability of tests for fibrinogen (fibrin) degradation products in plasma with thrombin coagulase, reptilase and thrombin clotting time (author's transl)].
    Wenzel E; Holzhüter H; Muschietti F; Angelkort B; Ochs HG; Pusztai-Markos S; Nowak H; Stürner H
    Dtsch Med Wochenschr; 1974 Apr; 99(15):746-56. PubMed ID: 4858105
    [No Abstract]   [Full Text] [Related]  

  • 30. The effect of heat on the clotting of plasma by staphylococcal coagulase and by thrombin with particular reference to the protective action of glycine.
    GORDON J; TURNER GC
    J Hyg (Lond); 1955 Jun; 53(2):129-32. PubMed ID: 14392311
    [No Abstract]   [Full Text] [Related]  

  • 31. PLASMA COAGULATION BY ORGANISMS OTHER THAN STAPHYLOCOCCUS AUREUS.
    BAYLISS BG; HALL ER
    J Bacteriol; 1965 Jan; 89(1):101-5. PubMed ID: 14255647
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clotting activity in Staphylococcus schleiferi subspecies from human patients.
    Vandenesch F; Lebeau C; Bes M; Lina G; Lina B; Greenland T; Benito Y; Brun Y; Fleurette J; Etienne J
    J Clin Microbiol; 1994 Feb; 32(2):388-92. PubMed ID: 8150947
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enzymatic properties of staphylothrombin, an active molecular complex formed between staphylocoagulase and human prothrombin.
    Kawabata S; Morita T; Iwanaga S; Igarashi H
    J Biochem; 1985 Dec; 98(6):1603-14. PubMed ID: 4093448
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structural basis for reduced staphylocoagulase-mediated bovine prothrombin activation.
    Friedrich R; Panizzi P; Kawabata S; Bode W; Bock PE; Fuentes-Prior P
    J Biol Chem; 2006 Jan; 281(2):1188-95. PubMed ID: 16230338
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of human thrombin assessed with different substrates and inhibitors. Characterization of fibrinopeptide binding interaction.
    Gorman JJ
    Biochim Biophys Acta; 1975 Dec; 412(2):273-82. PubMed ID: 1191680
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of hepes buffer on clotting tests, assay of factors V and VIII and on the hydrolysis of esters by thrombin and thrombokinase.
    Roberts PS; Hughes HN; Fleming PB
    Thromb Haemost; 1976 Feb; 35(1):202-10. PubMed ID: 989187
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cleavage of blood coagulation factor XIII and fibrinogen by thrombin during in vitro clotting.
    Greenberg CS; Miraglia CC; Rickles FR; Shuman MA
    J Clin Invest; 1985 May; 75(5):1463-70. PubMed ID: 2860124
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Staphylocoagulase is a prototype for the mechanism of cofactor-induced zymogen activation.
    Friedrich R; Panizzi P; Fuentes-Prior P; Richter K; Verhamme I; Anderson PJ; Kawabata S; Huber R; Bode W; Bock PE
    Nature; 2003 Oct; 425(6957):535-9. PubMed ID: 14523451
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The action of poly-lysine on the conversion of fibrinogen into fibrin by coagulase thrombin.
    BIEZUNSKI N; SHAFRIR E; DE VRIES A; KATCHALSKI E
    Biochem J; 1955 Jan; 59(1):55-8. PubMed ID: 14351141
    [No Abstract]   [Full Text] [Related]  

  • 40. [On the enzyme nature of staphylocoagulase].
    LIEB FL
    Arch Hyg Bakteriol; 1960 Feb; 144():32-6. PubMed ID: 14416810
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.